The evolving role of aromatase inhibitors in the treatment of early-stage breast cancer

被引：0
|
作者：
Paula D Ryan
Paul E Goss
机构：
[1] Director of the Breast and Ovarian Cancer Genetics Clinic at Massachusetts General Hospital and Assistant Professor of Medicine at Harvard Medical School,
[2] Director of Breast Cancer Research at Massachusetts General Hospital,undefined
[3] and Professor of Medicine at Harvard Medical School,undefined
来源：
Nature Clinical Practice Oncology | 2005年 / 2卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Substantial progress has been made using aromatase inhibitors in early-stage breast cancer. This article highlights results from recent and ongoing trials of aromatase inhibitors as adjuvant therapy and discusses options for integration of these agents with tamoxifen in various subsets of patients and clinical scenarios.
引用
下载
收藏
页码：596 / 597
页数：1
相关论文
共 50 条
12345